23 completed, 17 unknown, 3 terminated, 2 active not recruiting. 13 Phase 1, 11 Phase 2, 8 Not applicable, 4 Phase 3, 2 Phase 4.
Follow COVID-19 Vaccine: new trials by email Literature Review of COVID-19 Vaccine trials Research Report on COVID-19 Vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pancoronavirus Vaccine Study in Healthy Adults CoV-RBD-scNP-001 and 3M-052-AF - COVID-19 Respiratory Infection, SARS CoV 2 Infection | Phase 1 | Terminated | Duke University | 4 | 2025-08-01 | 2026-10-19 |
| Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine Thymalfasin (Thymosin alpha 1, Ta1) - Vaccine Response, COVID-19 Vaccine | Phase 1 | Recruiting | The Methodist Hospital Research Institute | 75 | 2024-12-02 | 2026-07-16 |
| Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases COVID-19 vaccine and booster training, and importance - Rheumatic Diseases, COVID-19 Vaccine | Not applicable | Active not recruiting | Northwestern University | 60 | 2024-03-15 | 2026-05-29 |
| Safety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine （CHO Cell）LYB002V14 in Booster Vaccination 30μg dose of LYB002V14, 60μg dose of LYB002V14, placebo - SARS-CoV-2, COVID-19 Vaccine | Phase 1 | Unknown | Guangzhou Patronus Biotech Co., Ltd. | 120 | 2023-12-26 | 2023-12-26 |
| Evaluation of Safety, Tolerability, Reactogenicity, Immunogenicity of Baiya SARS-CoV-2 Vax 2 as a Booster for COVID-19 50 μg Baiya SARS-CoV-2 Vax 2, Placebo - COVID-19 Vaccine, COVID-19 | Phase 2 | Unknown | Baiya Phytopharm Co., Ltd. | 75 | 2023-12-01 | 2023-11-15 |
| COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease SCD-specific COVID-19 vaccination information (SCVI) video - Sickle Cell Disease, COVID-19 Vaccine | Not applicable | Completed | Duke University | 33 | 2023-09-19 | 2024-12-24 |
| SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI Spinal Cord Injuries, Traumatic Spinal Cord Injury | Active not recruiting | Northwell Health | 140 | 2023-03-31 | 2026-04-03 | |
| ARVAC-A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine Gamma Variant RBD-based ARVAC-CG vaccine, Omicron Variant RBD-based ARVAC-CG vaccine, Bivalent RBD-based ARVAC-CG vaccine - COVID-19 Vaccine | Phase 2 / Phase 3 | Completed | Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno | 2014 | 2023-02-06 | 2023-12-22 |
| To Explore the Protective Effect of SARS-CoV-2 Vaccination on Cancer Patients Infected With SARS-CoV-2 no intervention - COVID-19 Infection, COVID-19 Vaccine | Unknown | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 700 | 2023-01-01 | 2023-03-17 | |
| Safety and Immunogenicity of the RNA MCTI CIMATEC HDT Vaccine RNA MCTI CIMATEC HDT 5µg, RNA MCTI CIMATEC HDT 10µg, Covishield® - AstraZeneca - COVID-19, COVID-19 Vaccine | Phase 2 | Unknown | Azidus Brasil | 300 | 2023-01-01 | 2022-09-15 |
| A Phase II/III Study of PIKA Recombinant SARS-CoV-2 Vaccine as a Booster Dose. PIKA COVID-19 vaccine, Inactivated Covid-19 vaccine - Covid-19 Vaccine | Phase 2 / Phase 3 | Completed | Yisheng Biopharma (Singapore) Pte. Ltd. | 5860 | 2022-10-03 | 2024-07-23 |
| COVID-19 Vaccine and Development of Immune Thrombocytopenic Purpura covid19 vaccines - COVID-19 Vaccine | Unknown | Assiut University | 500 | 2022-08-01 | 2022-07-13 | |
| A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 in Adults Aged 18 Years and Above MVC-COV1901, AZD1222 - COVID-19 Vaccine | Phase 3 | Completed | Medigen Vaccine Biologics Corp. | 250 | 2022-07-30 | 2023-10-23 |
| A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Vaccine Compared With AZD1222 MVC-COV1901, AZD1222 - COVID-19 Vaccine | Phase 3 | Completed | Medigen Vaccine Biologics Corp. | 200 | 2022-07-09 | 2023-10-23 |
| Efficacy and Safety of Covid-19 Vaccine in Cardiac Patients COVID-19 Vaccine | Unknown | Mina sobhi said fam | 50 | 2022-06-01 | 2022-04-27 | |
| A Study to Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901 or MVC-COV1901(Beta) Against COVID-19 MVC-COV1901, MVC-COV1901(Beta)-15, MVC-COV1901(Beta)-25 - COVID-19 Vaccine | Phase 1 | Completed | Medigen Vaccine Biologics Corp. | 107 | 2022-05-06 | 2023-03-15 |
| ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine ARVAC-CG vaccine (recombinant protein vaccine against SARS-CoV-2) - COVID-19 Vaccine | Phase 1 | Completed | Laboratorio Pablo Cassara S.R.L. | 80 | 2022-04-20 | 2023-12-22 |
| Evaluation of the Safety, Tolerability, and Reactogenicity of the Baiya SARS-CoV-2 Vax 2 Vaccine for COVID-19 Disease 25 Baiya SARS-CoV-2 Vax 2, 50 Baiya SARS-CoV-2 Vax 2 - COVID-19 Vaccine | Phase 1 | Unknown | Baiya Phytopharm Co., Ltd. | 24 | 2022-03-28 | 2023-05-24 |
| Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID and EG-COVARo in Healthy Adult Volunteers EG-COVID-003, EG-COVID-001, A: EG-COVID - COVID-19 Vaccine | Phase 1 / Phase 2 | Completed | EyeGene Inc. | 67 | 2022-03-22 | 2025-03-07 |
| Covid-19 Vaccine Response in Heart Transplant Recipients Biospecimen Collection, Questionnaire, Electronic Health Record Review - Heart Transplantation, COVID-19 Virus Infection | Completed | Assistance Publique - Hôpitaux de Paris | 190 | 2022-03-07 | 2024-01-03 |
Showing 20 of 47. Sign in to see all of them.
COVID-19 (20) · Vaccination Hesitancy (3) · Pneumonia, Viral (2) · Anemia, Iron-Deficiency (1) · Anemia, Sickle Cell (1) · Breast Feeding (1) · Coronavirus Infections (1) · Inflammation (1) · Influenza, Human (1) · Lyme Disease (1) · Myocarditis (1) · Neoplasms (1) · Rheumatic Diseases (1) · Sedentary Behavior (1) · Spinal Cord Injuries (1)
Infections (21) · RNA Virus Infections (21) · Respiratory Tract Diseases (21) · Respiratory Tract Infections (21) · Virus Diseases (21) · Coronaviridae Infections (20) · Lung Diseases (20) · Nidovirales Infections (20) · Pneumonia (20) · Coronavirus Infections (19) · Pneumonia, Viral (18) · Behavior (5) · Health Behavior (3) · Treatment Adherence and Compliance (3) · Treatment Refusal (3)
COVID-19 Vaccines (5) · MVC-COV1901 vaccine (4) · ChAdOx1 nCoV-19 (3) · 2019-nCoV Vaccine mRNA-1273 (1) · Ad5-nCoV vaccine (1) · Anti-Bacterial Agents (1) · BIBP COVID-19 vaccine (1) · BNT162 Vaccine (1) · COVAC-1 COVID-19 vaccine (1) · COVI-VAC (1) · ChulaCov19 vaccine (1) · Cross-Sectional Studies (1) · Gam-COVID-Vac vaccine (1) · NDV-HXP-S COVID-19 vaccine (1) · Saline Solution (1)
Medigen Vaccine Biologics Corp. (4) · Mahidol University (3) · Baiya Phytopharm Co., Ltd. (2) · Duke University (2) · Izmir Bakircay University (2) · Assistance Publique - Hôpitaux de Paris (1) · Assiut University (1) · Azidus Brasil (1) · Beijing 302 Hospital (1) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno (1) · Chinese University of Hong Kong (1) · Chulalongkorn University (1) · Deborah O'Connor (1) · Dr. Daniel Cameron & Associates (1)
United States (10) · Thailand (7) · Argentina (4) · Turkey (Türkiye) (4) · China (3) · Taiwan (3) · Canada (2) · Egypt (2) · Hong Kong (2) · Australia (1) · France (1) · Germany (1) · Israel (1) · Kenya (1) · Mexico (1)
Allen Lien, MD. Dr.PH (2) · Ahmed F Thabet, Professor (1) · Allen Lien, MD Dr.Ph (1) · Allen Lien, MD. DrPH (1) · Atibordee Meesing, MD (1) · Aydin Erenmemisoglu, Prof. (1) · Chayasin Mansanguan, M.D. (1) · Chieh-Yu Cheng, MD.PhD. (1) · Christina Chambers, PhD, MPH (1) · Dimpy Shah, MD PhD (1) · Gustavo Yerino, MD (1) · John Strouse, MD, PhD (1) · Jonpaul Sze Tsing Zee, MBChB (1) · Joyce WY Mak, FHKAM (1)
PMID 14579179, PMID 16339739, PMID 1984800, PMID 23324619, PMID 23714309, PMID 26436850, PMID 31770441, PMID 31950516, PMID 31978945, PMID 32123347, PMID 32235085, PMID 32252141, PMID 32337143, PMID 32418199, PMID 32864575, PMID 32941052, PMID 33102545, PMID 33199918, PMID 33245961, PMID 33647938, PMID 34030782, PMID 34580673, PMID 35284808, PMID 35449064, PMID 35577631, PMID 36006288, PMID 36310395, PMID 36454186, PMID 36460536, PMID 36574256, PMID 37080829, PMID 37095378, PMID 37507392, PMID 38287068, PMID 38458871, PMID 39181556, PMID 39525672, PMID 40179522, PMID 40237463
R01AI166967 (1)